Canopy Growth Corporation (CGC)

Market Cap	448.19M
Revenue (ttm)	200.02M
Net Income (ttm)	-277.01M
Shares Out	342.20M
EPS (ttm)	-1.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,618,236
Open	1.220
Previous Close	1.220
Day's Range	1.180 - 1.225
52-Week Range	0.770 - 2.900
Beta	2.15
Analysts	Hold
Price Target	n/a
Earnings Date	Feb 6, 2026

About CGC

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7A...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Luc Mongeau
• Employees: 960
• Stock Exchange: NASDAQ
• Ticker Symbol: CGC
• Website: https://www.canopygrowth.com

Financial Performance

In 2024, Canopy Growth's revenue was 269.00 million, a decrease of -9.47% compared to the previous year's 297.15 million. Losses were -598.12 million, -9.00% less than in 2023.

Financial numbers in CAD